UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the healthcare conglomerate’s stock after purchasing an additional 456 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in UnitedHealth Group were worth $1,168,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Bray Capital Advisors lifted its holdings in UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after acquiring an additional 50 shares during the period. 1900 Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $359,000. DAVENPORT & Co LLC increased its position in shares of UnitedHealth Group by 28.8% in the third quarter. DAVENPORT & Co LLC now owns 244,089 shares of the healthcare conglomerate’s stock valued at $123,220,000 after buying an additional 54,521 shares in the last quarter. BTC Capital Management Inc. increased its position in shares of UnitedHealth Group by 2.6% in the third quarter. BTC Capital Management Inc. now owns 14,925 shares of the healthcare conglomerate’s stock valued at $7,525,000 after buying an additional 375 shares in the last quarter. Finally, Bellecapital International Ltd. increased its position in shares of UnitedHealth Group by 2.0% during the third quarter. Bellecapital International Ltd. now owns 13,630 shares of the healthcare conglomerate’s stock worth $6,872,000 after purchasing an additional 273 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 0.2 %

UNH opened at $487.30 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The business has a 50 day simple moving average of $486.90 and a 200-day simple moving average of $514.57. The stock has a market capitalization of $448.35 billion, a P/E ratio of 29.79, a P/E/G ratio of 1.41 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm posted $6.26 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Barclays upped their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. TD Cowen decreased their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.